AzTrials
AzTrials

Ovarian StimulationNCT03298750

Mechanical Stimulation of the Ovary for Infertility Treatment in Patients With Very Low Ovarian Reserve

A study testing Resection of ovarian tissue and mechanical stimulation in people with Ovarian Stimulation, run by Sheba Medical Center.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Examine the possibility that mechanical stimulation and ovarian fragmentation in women with premature ovarian failure or low ovarian reserve intended for egg donation may cause early follicular recruitment and increase chances of achieving pregnancy through IVF. Read more about this study

Who is it for?
Ages 21 to 45 years, women onlyHealthy volunteers can take part
Conditions the study is for
Ovarian Stimulation
What is being tested?
Resection of ovarian tissue and mechanical stimulation
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
10 participants
Where
No sites listed yet
Study dates
20 Oct 2017to 1 Sep 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 to 45 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Healthy women, aged 21-40. with premature ovarian failure.
  • Healthy women, with poor ovarian reserve, aged 38-45, undergoing IVF Low ovarian response: recruitment of up to three eggs in previous treatments.
  • After the failure of at least 4 cycles.
  • Two functioning ovaries, follicular and hormonal response of both ovaries in prior therapies.
  • Women candidates for egg donation, and seeking further treatment before switching to egg donation.

Who cannot join

  • Women with kidney disease.
  • Women with infertility factors other than ovarian failure, such as endometriosis, PCOS, male factor.
  • Women with one non-functioning ovary, or that was removed.
  • Women with an intrauterine or pelvic pathology.

Trial locations and contacts

No sites are listed yet.

Alon Kedem, MD contact

972543456953

kedem2001@gmail.com

Noam Domniz, MD contact

972528899242

domniz@gmail.com

About this study

Examine the possibility that mechanical stimulation and ovarian fragmentation in women with premature ovarian failure or low ovarian reserve intended for egg donation may cause early follicular recruitment and increase chances of achieving pregnancy through IVF.

Read the detailed description

The women will undergo a surgical laparoscopy during which one of the two technique will ensue.

  1. One of the ovaries will be scratched ( 2 mm depth) with a knife. Simultaneously, a piece of the ovary will be preserved for further histologic analysis and research in the laboratory.
  2. A piece of one ovary will be resected (up to one third of the ovary's volume, without harming the other ovary.

The resected ovarian tissue will be transferred immediately to the laboratory where the cortex will be divided from the medulla and sliced to small pieces of 1-2 square millimeters.

These pieces will be transferred back to the operation room in order for them to be transplanted under the serosa layer of the remaining ovary.

Any bleeding would be stopped using a stiches or hemostatic mesh (diathermy will not be used).

Simultaneously, a piece of the ovary will be preserved for further histologic analysis and research in the laboratory.

Post operational follow up ( up to two years) including: menstrual cycle surveillance, hormonal profile, AMH level, US of the pelvis and Antral Follicles Count (AFC).

A month after the surgery, an ovarian stimulation will commence following IVF while close monitoring the ovarian response and comparing the pre and post operation response.

Moreover, the treated ovary will be compared to the untreated one: using the US the ovarian volume and antral follicles size and count will be evaluated.

The preserved pieces of ovary will be histologically evaluated for ovarian reserve analysis.

Additionally, these pieces will be used for experiments for the evaluation of various methods for primordial follicles stimulation including mechanical stimulation like the laser or using substances like Akt Stimulators.

Being tested
Resection of ovarian tissue and mechanical stimulation
Keywords
Mechanical Laboratory Ovarian Stimulation Poor responders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Resection of ovarian tissue and mechanical stimulationProcedure or surgery

    he women will undergo a surgical laparoscopy during which one of the two technique will ensue.

    1. One of the ovaries will be scratched ( 2 mm depth) with a knife. Simultaneously, a piece of the ovary will be preserved for further histologic analysis and research in the laboratory.
    2. A piece of one ovary will be resected (up to one third of the ovary's volume, without harming the other ovary.

    The resected ovarian tissue will be transferred immediately to the laboratory where the cortex will be divided from the medulla and sliced to small pieces of 1-2 square millimeters.

    These pieces will be transferred back to the operation room in order for them to be transplanted under the serosa layer of the remaining ovary.

    Any bleeding would be stopped using a stiches or hemostatic mesh (diathermy will not be used).

    Simultaneously, a piece of the ovary will be preserved for further histologic analysis and research in the laboratory.

Study groups in NCT03298750
Study groupRoleWhat they receive
Mechanical stimulationExperimentalMechanical stimulation of ovarian tissue
Receives: Procedure: Resection of ovarian tissue and mechanical stimulation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Menstrual cycle surveillance

    Duration of the menstrual period (days)

    Measured: 2 years

  2. AMH

    Ovarian reserve measurements. AMH levels ng/ml

    Measured: 2 years

  3. Estradiol

    Estradiol levels at day of HCG in Pmol/L

    Measured: 2 years

  4. Antral follicular count

    measurement of. any antral follicles at day 3-5 with ultrasound

    Measured: 2 years

  5. IVF outcomes

    Number of oocytes at OPU

    Measured: 2 years

  6. FSH levels

    FSH levels at. day 2-3 of menstruation IU/L

    Measured: 2 years

  7. IVF outcomes fertilization rates

    fertilization rate. - number of fertilized oocytes relatively to total number of oocytes

    Measured: 2 years

  8. IVF outcomes

    pregnancy rates

    Measured: 2 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Oct 2017
  2. Study start20 Oct 2017 (estimated)
  3. Primary completion1 Sep 2019 (estimated)
  4. Study completion1 Sep 2019 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
10 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03298750
Sponsor's protocol ID
SHEBA-15-2289-AK-CTIL
Status last verified
Oct 2017
First submitted
26 Jun 2016
Last updated
10 Oct 2017
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Resection of ovarian tissue and mechanical stimulation in people with Ovarian Stimulation, run by Sheba Medical Center.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 10 Oct 2017. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Alon Kedem, MD (972543456953, kedem2001@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Menstrual cycle surveillance (time frame: 2 years). The study lists 8 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Oct 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in